Dow Jones Newswires: AstraZeneca’s Forxiga gets EU approval recommendation for symptomatic chronic heart failure

The recommendation covers heart failure with reduced ejection fraction–a measure of the amount of blood the heart’s left ventricle pumps with each heartbeat.